Promise and Perils of Blood-based Signatures for Detecting Early-Onset Colorectal Cancer

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2022 Aug 12

PMID 35961378

Authors

Siddharth Singh

Samir Gupta

Affiliations

Soon will be listed here.

Citing Articles

Exploring the clinical significance of TPX2 in pancreatic cancer: from biomarker to immunotherapy.

Zhang Z, Liu Z, Yao Y, Li M, Shen C, Zhou F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39688710 DOI: 10.1007/s00210-024-03628-0.

CRCDB: A comprehensive database for integrating and analyzing multi-omics data of early-onset and late-onset colorectal cancer.

Zou D, Ning W, Xu L, Lei S, Wang L, Wang Z Comput Struct Biotechnol J. 2024; 23:2507-2515.

PMID: 38974887 PMC: 11225619. DOI: 10.1016/j.csbj.2024.05.051.

References

Patel S, May F, Anderson J, Burke C, Dominitz J, Gross S . Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2021; 162(1):285-299. DOI: 10.1053/j.gastro.2021.10.007. View

Nakamura K, Hernandez G, Sharma G, Wada Y, Banwait J, Gonzalez N . A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer. Gastroenterology. 2022; 163(5):1242-1251.e2. PMC: 9613521. DOI: 10.1053/j.gastro.2022.06.089. View

Sinicrope F . Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med. 2022; 386(16):1547-1558. DOI: 10.1056/NEJMra2200869. View

Rex D, Boland C, Dominitz J, Giardiello F, Johnson D, Kaltenbach T . Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017; 153(1):307-323. DOI: 10.1053/j.gastro.2017.05.013. View

Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E . Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 325(19):1965-1977. DOI: 10.1001/jama.2021.6238. View